Effektivitätsoptimierte und toxizitätsreduzierte Therapie des metastasierten Kolorektalkarzinoms in der First-line Therapie

ABSTRACT: Primary objectives: To verify the superiority of a combined chemo-immuno-therapy compared to exclusive chemotherapy. Primary endpoints: progression of tumor (new lesions or increase by more than 20% acc to RECIST criteria)

DISEASE(S): Colorectal Carcinoma,Metastastic Colorectal Cancer

PROVIDER: 2519927 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR